Depression and anxiety are the most common mental health illnesses, affecting 264 million and 284 million people worldwide, respectively – equivalent to 3.4% and 3.8% of the global population. However, it’s thought that many cases are unreported – the real figures are expected to be double what is recorded. What’s going on at a molecular level in the brain during depression and anxiety? How does medication change this?